Stereotaxis has announced that physicians at the University of Kansas Health System (Kansas City, USA)—a system renowned for diagnosing and treating complex heart conditions—have successfully treated the first patients using the company’s advanced Genesis robotic magnetic navigation (RMN) system.
According to a Stereotaxis press release, the Genesis system is the latest advancement in RMN technology, which introduces the benefits of robotic precision and safety to cardiac ablation in the treatment of arrhythmias.
“For years, advanced robot technology has been instrumental in our ability to deliver superior care to our patients, allowing us to navigate complex cardiac procedures with improved accuracy and safety,” said Seth Sheldon (University of Kansas Health System, Kansas City, USA). “The robotic precision and stability offered by the Genesis system allows us to deliver precise, personalised treatments to our patients, ultimately improving outcomes and quality of life.”
“We are proud to continue our partnership with the health system to deliver exceptional cardiac care to patients in Kansas City,” added David Fischel, chairman and chief executive officer (CEO) of Stereotaxis. “We look forward to continuing to support their successful and impactful robotic heart rhythm care programme.”
